Scarica l'app Stockscreener
115.84
0.66%
0.76
Dopo l'orario di chiusura:
125.00
9.16
+7.91%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché A Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$115.08
Aprire:
$116
Volume 24 ore:
2.93M
Relative Volume:
1.31
Capitalizzazione di mercato:
$32.74B
Reddito:
$7.07B
Utile/perdita netta:
$1.29B
Rapporto P/E:
25.54
EPS:
4.5355
Flusso di cassa netto:
$993.00M
1 W Prestazione:
+1.81%
1M Prestazione:
+0.19%
6M Prestazione:
-24.96%
1 anno Prestazione:
+4.12%
Intervallo 1D:
$115.02
$118.40
Intervallo di 1 settimana:
$111.06
$118.40
Portata 52W:
$108.35
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Nome
Agilent Technologies Inc
Settore
Industria
Telefono
(408) 345-8886
Indirizzo
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
115.84 | 32.52B | 7.07B | 1.29B | 993.00M | 4.5355 |
TMO
Thermo Fisher Scientific Inc
|
456.21 | 166.55B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
173.13 | 122.31B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
550.99 | 43.95B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
342.18 | 33.25B | 3.77B | 449.25M | 240.68M | 7.8556 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Iniziato | HSBC Securities | Buy |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-11-17 | Downgrade | UBS | Buy → Neutral |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Reiterato | Barclays | Equal Weight |
| 2023-05-24 | Reiterato | BofA Securities | Buy |
| 2023-05-24 | Reiterato | Citigroup | Neutral |
| 2023-05-24 | Reiterato | Credit Suisse | Outperform |
| 2023-05-24 | Reiterato | Evercore ISI | Outperform |
| 2023-05-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Reiterato | Robert W. Baird | Outperform |
| 2023-05-24 | Reiterato | SVB Securities | Outperform |
| 2023-05-24 | Reiterato | Stifel | Hold |
| 2023-05-24 | Reiterato | TD Cowen | Outperform |
| 2023-05-24 | Reiterato | Wells Fargo | Overweight |
| 2023-05-11 | Iniziato | Barclays | Equal Weight |
| 2023-01-10 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-07-08 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Reiterato | BofA Securities | Buy |
| 2022-02-23 | Reiterato | Citigroup | Buy |
| 2022-02-23 | Reiterato | Cowen | Outperform |
| 2022-02-23 | Reiterato | Evercore ISI | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-23 | Reiterato | Wells Fargo | Overweight |
| 2021-11-23 | Reiterato | BofA Securities | Buy |
| 2021-11-23 | Reiterato | Cowen | Outperform |
| 2021-11-23 | Reiterato | Stifel | Hold |
| 2021-03-18 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Aggiornamento | UBS | Neutral → Buy |
| 2020-11-17 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Iniziato | Atlantic Equities | Neutral |
| 2020-08-19 | Reiterato | BofA Securities | Neutral |
| 2020-08-19 | Reiterato | Citigroup | Neutral |
| 2020-08-19 | Reiterato | Jefferies | Buy |
| 2020-08-19 | Reiterato | Robert W. Baird | Outperform |
| 2020-08-19 | Reiterato | SVB Leerink | Outperform |
| 2020-08-19 | Reiterato | Stifel | Hold |
| 2020-08-19 | Reiterato | Wells Fargo | Overweight |
| 2020-02-24 | Downgrade | Needham | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-26 | Reiterato | Needham | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | UBS | Buy → Neutral |
| 2019-07-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Downgrade | Barclays | Overweight → Equal Weight |
Mostra tutto
Agilent Technologies Inc Borsa (A) Ultime notizie
Agilent Technologies Inc (A) Q2 2026 Earnings Call Highlights: S - GuruFocus
Agilent raises 2026 profit forecast on strong demand for lab tools - WSAU
Agilent Technologies Q2 Earnings Call Highlights - Yahoo Finance
Agilent (A) Q2 2026 Earnings Call Transcript - AOL.com
Earnings call transcript: Agilent Technologies Q2 2026 beats expectations By Investing.com - Investing.com Australia
Agilent Lifted Its 2026 Profit Outlook On Strong Lab Demand - Finimize
Agilent Technologies (A) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance UK
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Agilent (A) Reports Strong Q2 Revenue Exceeding Expectations - GuruFocus
Agilent Technologies Inc reports results for the quarter ended April 30Earnings Summary - TradingView
Agilent rises on Q2 beats; adjusts fiscal 2026 guidance - Seeking Alpha
Agilent Technologies earnings beat by $0.08, revenue topped estimates - Investing.com Nigeria
Is Agilent Technologies Inc (A) Undervalued After Q2 Earnings Be - GuruFocus
Agilent surges 8% on earnings beat and raised guidance By Investing.com - Investing.com Nigeria
Agilent (A) Reports Strong Q2 Results, Shares Jump 5.5% - GuruFocus
Agilent grows Q2 revenue to $1.83B, raises 2026 guidance - Stock Titan
Agilent Technologies Fiscal Q2 Adjusted Earnings, Revenue Rise; Shares Gain After Hours - marketscreener.com
Agilent (NYSE:A) Surprises With Q1 CY2026 Sales, Stock Soars - Yahoo Finance
Agilent: Fiscal Q2 Earnings Snapshot - WKYC
(A) Agilent Technologies, Inc. Expects Q3 Revenue Range $1.83B$1.85B - marketscreener.com
(A) Agilent Technologies, Inc. Expects Q3 Adjusted EPS Range $1.48$1.50 - marketscreener.com
Earnings Flash (A) Agilent Technologies, Inc. Reports Q2 Revenue $1.83B, vs. FactSet Est of $1.80B - marketscreener.com
Earnings Flash (A) Agilent Technologies, Inc. Posts Q2 Adjusted EPS $1.49 per Share, vs. FactSet Est of $1.41 - marketscreener.com
Agilent (NYSE: A) delivers strong Q2 2026 results and lifts full-year guidance - Stock Titan
Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results - The Joplin Globe
Agilent Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2026 - marketscreener.com
Agilent (A) Set to Report Earnings with Consensus at $1.41 - GuruFocus
Agilent Facing Product Cycle Momentum Across Key Platforms, RBC Says - Moomoo
Agilent Technologies stock (US00846U1016): RBC keeps bullish stance before Q2 earnings - AD HOC NEWS
RBC Capital Maintains Agilent Technologies(A.US) With Buy Rating, Maintains Target Price $153 - Moomoo
Agilent Technologies (A) Receives Outperform Rating with $153 Ta - GuruFocus
Agilent earnings up next: Can pharma strength offset market headwinds? By Investing.com - Investing.com Nigeria
Agilent earnings up next: Can pharma strength offset market headwinds? - Investing.com
RBC Initiates Agilent Technologies at Outperform With $153 Price Target - marketscreener.com
Agilent stock initiated at Outperform by RBC Capital with $153 target By Investing.com - Investing.com Australia
Agilent Technologies FY 2026 earnings preview - MSN
Agilent stock initiated at Outperform by RBC Capital with $153 target - Investing.com Australia
Agilent (A) Launches Innovative Workflow for Pharmaceutical Qual - GuruFocus
Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control - pharmiweb.com
Baird Maintains Agilent Technologies(A.US) With Buy Rating, Raises Target Price to $156 - Moomoo
Agilent launches gas chromatographs with remote diagnostics - Investing.com UK
Agilent (A) Unveils Advanced Gas Chromatography Systems - GuruFocus
Agilent Technologies Inc (STU:AG8) Q2 2026: Everything You Need to Know Ahead of Earnings - GuruFocus
AAgilent Technologies Inc Stock Price and Quote - Finviz
Agilent launches gas chromatographs with remote diagnostics By Investing.com - Investing.com Canada
Agilent Launches New GC Systems with GC Assist to Improve Laboratory Efficiency and Data Quality - The Joplin Globe
New Agilent lab systems flag results outside quality limits to reduce reruns - Stock Titan
What To Expect From Agilent’s (A) Q1 Earnings - Yahoo Finance
Agilent Technologies price faces pivotal resistanceForecast today25-05-2026 - Economies.com
Agilent Technologies (A) Stock Analysis: A Diagnostic Powerhouse with 40% Upside Potential - DirectorsTalk Interviews
Agilent Tech Q2 Net Drops, Job Cuts and Share Repurchase Widening Announced - AOL.com
Agilent Technologies Inc Azioni (A) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.05%
0.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):